Comments

BridgeBio Pharma Analyst Ratings

BBIONASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$71.36

-0.31-0.43%

Last update: Dec 10, 9:30 AM

Overview News Earnings Options

Analyst Ratings

Insider Trades Short Interest Government Trades Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$110.00

Lowest Price Target¹

$27.00

Consensus Price Target¹

$65.50

BridgeBio Pharma Analyst Ratings and Price Targets | NASDAQ:BBIO | Benzinga

BridgeBio Pharma Inc has a consensus price target of $65.5 based on the ratings of 27 analysts. The high is $110 issued by Cantor Fitzgerald on October 30, 2025. The low is $27 issued by SVB Securities on April 13, 2023. The 3 most-recent analyst ratings were released by Wells Fargo, JP Morgan, and HC Wainwright & Co. on November 11, 2025, November 7, 2025, and November 3, 2025, respectively. With an average price target of $83.67 between Wells Fargo, JP Morgan, and HC Wainwright & Co., there's an implied 17.25% upside for BridgeBio Pharma Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Wells Fargo

JP Morgan

HC Wainwright & Co.

Goldman Sachs

TD Cowen

¹calculated from analyst ratings

Analyst Ratings for BridgeBio Pharma

					Get Alert
Nov 11, 2025	17.71%	Derek ArchilaWells Fargo 70%	76 84	Previous Overweight Current Overweight	Get Alert
Nov 7, 2025	7.9%	Anupam RamaJP Morgan 73%	76 77	Previous Overweight Current Overweight	Get Alert
Nov 3, 2025	26.12%	Raghuram SelvarajuHC Wainwright & Co. 65%	90 90	Previous Buy Current Buy	Get Alert
Oct 31, 2025	40.13%	Paul ChoiGoldman Sachs 62%	55 100	Previous Buy Current Buy	Get Alert
Oct 30, 2025	33.13%	Tyler Van BurenTD Cowen 53%	60 95	Previous Buy Current Buy	Get Alert
Oct 30, 2025	-0.5%	Martin AusterRaymond James 66%	69 71	Previous Outperform Current Outperform	Get Alert
Oct 30, 2025	54.15%	Josh SchimmerCantor Fitzgerald 70%	100 110	Previous Overweight Current Overweight	Get Alert
Oct 30, 2025	37.33%	Biren AminPiper Sandler 58%	93 98	Previous Overweight Current Overweight	Get Alert
Oct 30, 2025	12.11%	Danielle BrillTruist Securities 63%	66 80	Previous Buy Current Buy	Get Alert
Oct 29, 2025	26.12%	Raghuram SelvarajuHC Wainwright & Co. 65%	80 90	Previous Buy Current Buy	Get Alert
Oct 27, 2025	12.11%	Raghuram SelvarajuHC Wainwright & Co. 65%	70 80	Previous Buy Current Buy	Get Alert
Oct 21, 2025	-17.32%	Martin AusterRaymond James 66%	56 59	Previous Outperform Current Outperform	Get Alert
Sep 15, 2025	-1.91%	Raghuram SelvarajuHC Wainwright & Co. 65%	70 70	Previous Buy Current Buy	Get Alert
Sep 12, 2025	14.91%	Eliana MerleUBS 63%	72 82	Previous Buy Current Buy	Get Alert
Sep 3, 2025	-1.91%	Anupam RamaJP Morgan 73%	55 70	Previous Overweight Current Overweight	Get Alert
Sep 3, 2025	-1.91%	Raghuram SelvarajuHC Wainwright & Co. 65%	70 70	Previous Buy Current Buy	Get Alert
Aug 29, 2025	-1.91%	Raghuram SelvarajuHC Wainwright & Co. 65%	56 70	Previous Buy Current Buy	Get Alert
Aug 8, 2025	-22.93%	Anupam RamaJP Morgan 73%	55 58	Previous Overweight Current Overweight	Get Alert
Aug 6, 2025	-20.12%	Greg HarrisonScotiabank 76%	55 57	Previous Sector Outperform Current Sector Outperform	Get Alert
Aug 6, 2025	-14.52%	Leland GershellOppenheimer 75%	60 61	Previous Outperform Current Outperform	Get Alert
Jul 29, 2025	33.13%	Josh SchimmerCantor Fitzgerald 70%	95 95	Previous Overweight Current Overweight	Get Alert
Jul 21, 2025	-7.51%	Danielle BrillTruist Securities 63%	66	Previous Initiates Current Buy	Get Alert
Jul 14, 2025	-4.71%	Biren AminPiper Sandler 58%	63 68	Previous Overweight Current Overweight	Get Alert
Jul 14, 2025	-1.91%	Andrew TsaiJefferies 43%	70	Previous Initiates Current Buy	Get Alert
Jul 11, 2025	-6.11%	David LebowitzCitigroup 69%	58 67	Previous Buy Current Buy	Get Alert
Jul 9, 2025	-15.92%	Leland GershellOppenheimer 75%	60 60	Previous Perform Current Outperform	Get Alert
Jun 30, 2025	6.5%	Tiago FauthWells Fargo 55%	67 76	Previous Overweight Current Overweight	Get Alert
Jun 25, 2025	-24.33%	Geoff MeachamB of A Securities 72%	50 54	Previous Buy Current Buy	Get Alert
Jun 17, 2025	-31.33%	Andy ChenWolfe Research 70%	49	Previous Initiates Current Outperform	Get Alert
Jun 9, 2025	-21.52%	Raghuram SelvarajuHC Wainwright & Co. 65%	53 56	Previous Buy Current Buy	Get Alert
Apr 30, 2025	-22.93%	Greg HarrisonScotiabank 76%	52 55	Previous Sector Outperform Current Sector Outperform	Get Alert
Apr 30, 2025	-11.72%	Biren AminPiper Sandler 58%	46 63	Previous Overweight Current Overweight	Get Alert
Apr 30, 2025	0.9%	Eliana MerleUBS 63%	65 72	Previous Buy Current Buy	Get Alert
Apr 15, 2025	-25.73%	Raghuram SelvarajuHC Wainwright & Co. 65%	49 53	Previous Buy Current Buy	Get Alert
Mar 31, 2025	-29.93%	Joshua Smith Redburn Atlantic 75%	50	Previous Initiates Current Buy	Get Alert
Mar 24, 2025	-29.93%	Anupam RamaJP Morgan 73%	44 50	Previous Overweight Current Overweight	Get Alert
Feb 21, 2025	-31.33%	David LebowitzCitigroup 69%	45 49	Previous Buy Current Buy	Get Alert
Feb 21, 2025	33.13%	Josh SchimmerCantor Fitzgerald 70%	95 95	Previous Overweight Current Overweight	Get Alert
Feb 21, 2025	-27.13%	Greg HarrisonScotiabank 76%	49 52	Previous Sector Outperform Current Sector Outperform	Get Alert
Feb 20, 2025	33.13%	Josh SchimmerCantor Fitzgerald 70%	70 95	Previous Overweight Current Overweight	Get Alert
Feb 13, 2025	-31.33%	Raghuram SelvarajuHC Wainwright & Co. 65%	49 49	Previous Buy Current Buy	Get Alert
Feb 12, 2025	-31.33%	Greg HarrisonScotiabank 76%	48 49	Previous Sector Outperform Current Sector Outperform	Get Alert
Dec 23, 2024	-29.93%	Cory KasimovEvercore ISI Group 69%	45 50	Previous Outperform Current Outperform	Get Alert
Dec 16, 2024	-31.33%	Raghuram SelvarajuHC Wainwright & Co. 65%	49 49	Previous Buy Current Buy	Get Alert
Nov 25, 2024	-32.74%	Greg HarrisonScotiabank 76%	45 48	Previous Sector Outperform Current Sector Outperform	Get Alert
Nov 25, 2024	-36.94%	Geoff MeachamB of A Securities 72%	42 45	Previous Buy Current Buy	Get Alert
Nov 25, 2024	-31.33%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 49	Previous Buy Current Buy	Get Alert
Nov 15, 2024	-36.94%	Greg HarrisonScotiabank 76%	44 45	Previous Sector Outperform Current Sector Outperform	Get Alert
Oct 25, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Oct 17, 2024	-35.54%	Mani ForooharLeerink Partners 56%	46 47	Previous Outperform Current Outperform	Get Alert
Oct 16, 2024	-38.34%	Greg HarrisonScotiabank 76%	44	Previous Initiates Current Sector Outperform	Get Alert
Oct 3, 2024	—	Leland GershellOppenheimer 75%	—	Previous Initiates Current Perform	Get Alert
Oct 2, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Sep 30, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Sep 17, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Sep 16, 2024	-1.91%	Josh SchimmerCantor Fitzgerald 70%	70 70	Previous Overweight Current Overweight	Get Alert
Sep 16, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Sep 11, 2024	-41.14%	Geoff MeachamB of A Securities 72%	42 42	Previous Buy Current Buy	Get Alert
Sep 9, 2024	-1.91%	Josh SchimmerCantor Fitzgerald 70%	70 70	Previous Overweight Current Overweight	Get Alert
Sep 4, 2024	-35.54%	Biren AminPiper Sandler 58%	46	Previous Initiates Current Overweight	Get Alert
Sep 3, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Aug 27, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Aug 22, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Aug 7, 2024	-39.74%	Anupam RamaJP Morgan 73%	43 46	Previous Overweight Current Overweight	Get Alert
Aug 7, 2024	-36.94%	Cory KasimovEvercore ISI Group 69%	45 50	Previous Outperform Current Outperform	Get Alert
Aug 5, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Aug 2, 2024	-36.94%	David LebowitzCitigroup 69%	45 46	Previous Buy Current Buy	Get Alert
Jul 1, 2024	-1.91%	Josh SchimmerCantor Fitzgerald 70%	70 70	Previous Overweight Current Overweight	Get Alert
Jun 25, 2024	-41.14%	Geoff MeachamB of A Securities 72%	42 50	Previous Buy Current Buy	Get Alert
Jun 20, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
Jun 5, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
May 30, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 43	Previous Buy Current Buy	Get Alert
May 28, 2024	-1.91%	Josh SchimmerCantor Fitzgerald 70%	70 70	Previous Overweight Current Overweight	Get Alert
May 28, 2024	-34.14%	Eliana MerleUBS 63%	47 51	Previous Buy Current Buy	Get Alert
May 20, 2024	-39.74%	Raghuram SelvarajuHC Wainwright & Co. 65%	43 47	Previous Buy Current Buy	Get Alert
May 14, 2024	-29.93%	Cory KasimovEvercore ISI Group 69%	50	Previous Initiates Current Outperform	Get Alert
Mar 20, 2024	-36.94%	Anupam RamaJP Morgan 73%	35 45	Previous Overweight Current Overweight	Get Alert
Mar 19, 2024	-1.91%	Josh SchimmerCantor Fitzgerald 70%	60 70	Previous Overweight Current Overweight	Get Alert
Mar 11, 2024	-15.92%	Josh SchimmerCantor Fitzgerald 70%	50 60	Previous Overweight Current Overweight	Get Alert
Mar 5, 2024	-25.73%	Salim SyedMizuho 50%	53 60	Previous Buy Current Buy	Get Alert
Mar 4, 2024	-34.14%	Raghuram SelvarajuHC Wainwright & Co. 65%	47 47	Previous Buy Current Buy	Get Alert
Feb 23, 2024	-35.54%	David LebowitzCitigroup 69%	42 46	Previous Buy Current Buy	Get Alert
Jan 31, 2024	-48.15%	Kostas BiliourisBMO Capital 40%	37	Previous Initiates Current Market Perform	Get Alert
Jan 29, 2024	-34.14%	Raghuram SelvarajuHC Wainwright & Co. 65%	22 47	Previous Buy Current Buy	Get Alert
Jan 22, 2024	-29.93%	Josh SchimmerCantor Fitzgerald 70%	50 50	Previous Overweight Current Overweight	Get Alert
Nov 7, 2023	-41.14%	David LebowitzCitigroup 69%	42	Previous Initiates Current Buy	Get Alert
Oct 24, 2023	-29.93%	Josh SchimmerCantor Fitzgerald 70%	50	Previous Initiates Current Overweight	Get Alert
Aug 28, 2023	-15.92%	Salim SyedMizuho 50%	60	Previous Buy Current Buy	Get Alert
Aug 17, 2023	-46.75%	Anupam RamaJP Morgan 73%	38 42	Previous Overweight Current Overweight	Get Alert
Aug 14, 2023	-15.92%	Salim SyedMizuho 50%	50 60	Previous Buy Current Buy	Get Alert
Jul 18, 2023	-29.93%	Paul ChoiGoldman Sachs 62%	29 50	Previous Buy Current Buy	Get Alert
Jul 18, 2023	-35.54%	Dane LeoneRaymond James 42%	29 46	Previous Outperform Current Outperform	Get Alert
Jul 18, 2023	-53.76%	Eun YangJefferies 33%	24 33	Previous Buy Current Hold	Get Alert
May 8, 2023	-59.36%	Salim SyedMizuho 50%	23 29	Previous Current Buy	Get Alert
Apr 19, 2023	-43.95%	Josh SchimmerEvercore ISI Group 70%	40	Previous Initiates Current Outperform	Get Alert
Apr 13, 2023	-62.16%	Mani ForooharSVB Securities 56%	25 27	Previous Current Outperform	Get Alert
Mar 7, 2023	-67.77%	Anupam RamaJP Morgan 73%	18 23	Previous Current Overweight	Get Alert
Mar 7, 2023	-60.76%	Paul ChoiGoldman Sachs 62%	20 28	Previous Current Buy	Get Alert
Mar 7, 2023	-59.36%	Dane LeoneRaymond James 42%	17 29	Previous Current Outperform	Get Alert
Feb 6, 2023	—	Tyler Van BurenCowen & Co. 53%	—	Previous Initiates Current Outperform	Get Alert

FAQ

What is the target price for BridgeBio Pharma (BBIO) stock?

The latest price target for BridgeBio Pharma (NASDAQ:BBIO) was reported by Wells Fargo on November 11, 2025. The analyst firm set a price target for $84.00 expecting BBIO to rise to within 12 months (a possible 17.71% upside). 44 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for BridgeBio Pharma (BBIO)?

The latest analyst rating for BridgeBio Pharma (NASDAQ:BBIO) was provided by Wells Fargo, and BridgeBio Pharma maintained their overweight rating.

When was the last upgrade for BridgeBio Pharma (BBIO)?

The last upgrade for BridgeBio Pharma Inc happened on July 9, 2025 when Oppenheimer raised their price target to $60. Oppenheimer previously had a perform for BridgeBio Pharma Inc.

When was the last downgrade for BridgeBio Pharma (BBIO)?

The last downgrade for BridgeBio Pharma Inc happened on July 18, 2023 when Jefferies changed their price target from $24 to $33 for BridgeBio Pharma Inc.

When is the next analyst rating going to be posted or updated for BridgeBio Pharma (BBIO)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BridgeBio Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BridgeBio Pharma was filed on November 11, 2025 so you should expect the next rating to be made available sometime around November 11, 2026.

Is the Analyst Rating BridgeBio Pharma (BBIO) correct?

While ratings are subjective and will change, the latest BridgeBio Pharma (BBIO) rating was a maintained with a price target of $76.00 to $84.00. The current price BridgeBio Pharma (BBIO) is trading at is $71.36, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.